Albendazole Tablet Franchise in Ahmedabad

Womfly 200 Tablet Supplier in Mumbai

Anthelmintic Tablet Distributor in Delhi

Albendazole Tablet Manufacturer in Bangalore

Deworming Tablet Stockist in Hyderabad
Albendazole Tablet Exporter in Chandigarh

Home/Products /albendazole-200mg-tablet

Womfly 200 Tablet

Composition : Albendazole (200mg) Tablet

Dosage Form : Tablet

Packaging Type : Blister

Packaging : 10*10

Price : ₹1/-

Womfly 200 Tablet contains Albendazole 200 mg, a broad-spectrum anthelmintic agent widely used for the treatment of intestinal and tissue parasitic worm infestations. It works by inhibiting microtubule formation and glucose uptake in parasites, leading to depletion of energy stores and eventual parasite death.

Albendazole is clinically effective against roundworms, hookworms, pinworms, whipworms, and other helminthic infections, making it a cornerstone therapy in deworming protocols for both adults and pediatric patients under medical supervision.

This tablet plays a critical role in controlling parasitic infections, improving nutritional absorption, and preventing complications related to chronic helminthiasis. The formulation ensures accurate dosing, consistent bioavailability, and dependable therapeutic response, essential for effective parasite eradication.

Womfly 200 Tablet is well-suited for hospitals, clinics, government health programs, pediatric practices, and retail pharmacies, where reliable and affordable anthelmintic therapy is required.


Read More

About the Product

Womfly 200 Tablet contains Albendazole 200 mg, a broad-spectrum anthelmintic agent widely used for the treatment of intestinal and tissue parasitic worm infestations. It works by inhibiting microtubule formation and glucose uptake in parasites, leading to depletion of energy stores and eventual parasite death.

Albendazole is clinically effective against roundworms, hookworms, pinworms, whipworms, and other helminthic infections, making it a cornerstone therapy in deworming protocols for both adults and pediatric patients under medical supervision.

This tablet plays a critical role in controlling parasitic infections, improving nutritional absorption, and preventing complications related to chronic helminthiasis. The formulation ensures accurate dosing, consistent bioavailability, and dependable therapeutic response, essential for effective parasite eradication.

Womfly 200 Tablet is well-suited for hospitals, clinics, government health programs, pediatric practices, and retail pharmacies, where reliable and affordable anthelmintic therapy is required.


Common side effects may include nausea, abdominal pain, vomiting, dizziness, or headache. Rarely, elevated liver enzymes, allergic reactions, or hair thinning may occur with prolonged use.

Womfly 200 Tablet is indicated for the treatment of intestinal helminthic infestations such as roundworm, hookworm, pinworm, threadworm, and other susceptible parasitic worm infections.

Womfly 200 Tablet should be taken strictly as prescribed by a physician. Use with caution in patients with liver disorders. Not recommended during pregnancy unless clearly advised by a healthcare professional. Regular monitoring may be required during long-term therapy.

Store in a cool, dry place below 25°C. Protect from moisture and direct sunlight. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation